MARKET

GCVRZ

GCVRZ

Sanofi FR
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8706
+0.0005
+0.06%
Closed 16:00 02/21 EST
OPEN
0.8700
PREV CLOSE
0.8701
HIGH
0.8706
LOW
0.8700
VOLUME
82.65K
TURNOVER
--
52 WEEK HIGH
0.8795
52 WEEK LOW
0.1529
MARKET CAP
1.09B
P/E (TTM)
0.3344
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GCVRZ and other stocks commission-free!

Open a Webull account and fund it to get a free stock

GCVRZ News

More
  • A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
  • MotleyFool.com · 7h ago
  • Oscar Health Cuts Co-Pays on About 100 Drugs to $3
  • MotleyFool.com · 7h ago
  • Investors Scrambled to Buy This Biotech IPO
  • MotleyFool.com · 10h ago
  • Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval
  • Zacks · 11h ago

Industry

Pharmaceuticals
+0.60%
Pharmaceuticals & Medical Research
+0.55%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About GCVRZ

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
More

Webull offers kinds of Sanofi SA stock information, including NASDAQ:GCVRZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCVRZ stock news, and many more online research tools to help you make informed decisions.